Genetic mutations in the EGFR gene occur in approximately 20%–50% of patients with NSCLC, depending on their ethnic background (Rosell et al., 2009; Pao and Chmielecki, 2010; Cancer Genome Atlas Research, 2014; Shi et al., 2014). Here, EGFR is linked to non-small cell lung carcinoma.